Table 1 Baseline demographic and clinical characteristics of the participants
Variables | CSF group (n = 60) Mean ± SD Number (%) | Control group (n = 60) Mean ± SD Number (%) | p-value |
|---|---|---|---|
Male gender | 44(73.3) | 27(45.0) | 0.002* |
Age (years) | 44.58 ± 4.92 | 43.53 ± 5.01 | 0.249 |
Hypertension, n (%) | 34 (56.7) | 19 (31.7) | 0.006* |
Diabetes mellitus, n (%) | 22 (36.7) | 18 (30) | 0.439 |
Smoking, n (%) | 44 (73.3) | 18 (30) | < 0.001* |
Dyslipidemia, n (%) | 31 (51.7) | 21 (35) | 0.65 |
Family history of premature CAD, n (%) | 21 (35) | 16 (26.7) | 0.323 |
Medications | |||
Aspirin | 36 (60) | 33 (55) | 0.58 |
Beta-blockers | 24 (40) | 20 (33.3) | 0.44 |
ACEIs/ ARBs | 15 (25) | 13 (21.7) | 0.67 |
Calcium channel blockers | 12 (20) | 9 (15) | 0.42 |
Nitrates | 24 (40) | 27 (45) | 0.58 |
Statins | 27 (45) | 32 (53.3) | 0.52 |
BMI (kg/m2) | 27.29 ± 2.63 | 25.7 ± 2.69 | 0.001* |
Diastolic blood pressure (mmHg) | 80.73 ± 2.46 | 80.62 ± 4.93 | 0.87 |
Systolic blood pressure (mmHg) | 116.65 ± 12.96 | 119.67 ± 11.4 | 0.184 |
Heart rate (bpm) | 80.38 ± 9.21 | 77.53 ± 7.599 | 0.067 |